Skip to main content
. 2022;15(4):406–414. doi: 10.22037/ghfbb.v15i4.2593

Table 3.

NAFLD activity score of mice treated with WD and CCl4

duration treatment steatosis inflammation ballooning NAS score Fibrosis stage
control 0.0 0.0 0.0 0.0 0.0
6 -7 1.5 1.25 0.0 2.75 1B
8-9 2.25 2.5 2 6.75 1C
10-11 2 2.25 1.25 5.5 3